BC Innovations | Aug 29, 2018
Distillery Therapeutics


INDICATION: Cervical cancer; skin cancer Mouse studies suggest a vaccine based on a nanoparticle-HpV16gp2 peptide conjugate could help treat human papillomavirus (HPV)-associated cancers. The conjugate consists of nanoparticles with a polypropylene sulfide core and HpV16gp2...
BC Week In Review | May 31, 2017
Company News

Advaxis, BMS partner to evaluate ADXS-DUAL plus Opdivo in cervical cancer

Advaxis Inc. (NASDAQ:ADXS) will sponsor a clinical trial evaluating its ADXS-DUAL in combination with PD-1 inhibitor Opdivo nivolumab to treat metastatic cervical cancer. The trial is slated to start this year. ADXS-DUAL is the second-generation...
Items per page:
1 - 2 of 2